Inflammatory Bowel Disease Cohort in Nantes
NCT06256393 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2025-02-10
Summary
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Conditions
- Inflammatory Bowel Diseases
Interventions
- OTHER
-
Collection of biological samples
Collection of blood samples and intestinal biopsies during a surgery or colonoscopy for disease relapse
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-04
- Primary Completion
- 2028-02-29
- Completion
- 2031-02-28
Countries
- France
Study Locations
More Related Trials
-
Validation Study for Disability Assessment Functional of Patients With Inflammatory Diseases Intestinal Chronic (VALIDate)
NCT03590639 ·Status: COMPLETED
-
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
NCT03359642 ·Status: COMPLETED ·Phase: NA
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases
NCT03426683 ·Status: COMPLETED ·Phase: NA
-
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
NCT02826330 ·Status: COMPLETED
-
Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain
NCT03689257 ·Status: COMPLETED
-
Identification/Characterization of Changes in Microscopic Colitis
NCT03063957 ·Status: UNKNOWN
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Genetic an Functional Studies of Patient With Inflammatory Bowel Disease
NCT03751722 ·Status: COMPLETED
-
Pathogenic Study of Adult Immune Enteropathies
NCT04280510 ·Status: RECRUITING
-
Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess
NCT02856763 ·Status: COMPLETED
-
NKT Role in the Regulation of the Inflammatory Bowel Disease
NCT02884557 ·Status: COMPLETED ·Phase: NA
-
Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic
NCT04344249 ·Status: COMPLETED
-
Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease
NCT02847052 ·Status: TERMINATED
-
Intestinal Organoids
NCT05294107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease
NCT02693340 ·Status: UNKNOWN
-
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
NCT05456893 ·Status: RECRUITING
-
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
NCT06619990 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities
NCT01216514 ·Status: COMPLETED
-
Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences
NCT02883296 ·Status: COMPLETED ·Phase: NA
-
The Fecal Microbiota Transplantation Registry
NCT03787771 ·Status: RECRUITING
-
Early Inflammatory Bowel Disease Progression
NCT06756100 ·Status: RECRUITING
-
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
NCT02502552 ·Status: COMPLETED